SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-14-001653
Filing Date
2014-03-03
Accepted
2014-03-03 11:36:18
Documents
13
Period of Report
2013-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a2218459z10-k.htm 10-K 1360185
2 EX-21.0 a2218459zex-21_0.htm EX-21.0 3286
3 EX-23.1 a2218459zex-23_1.htm EX-23.1 2844
4 EX-31.1 a2218459zex-31_1.htm EX-31.1 8862
5 EX-31.2 a2218459zex-31_2.htm EX-31.2 8677
6 EX-32 a2218459zex-32.htm EX-32 7415
13 G621270.JPG g621270.jpg GRAPHIC 46594
  Complete submission text file 0001047469-14-001653.txt   9209025

Data Files

Seq Description Document Type Size
7 EX-101.INS cldx-20131231.xml EX-101.INS 1175596
8 EX-101.SCH cldx-20131231.xsd EX-101.SCH 75049
9 EX-101.CAL cldx-20131231_cal.xml EX-101.CAL 118103
10 EX-101.LAB cldx-20131231_lab.xml EX-101.LAB 1242720
11 EX-101.PRE cldx-20131231_pre.xml EX-101.PRE 580582
12 EX-101.DEF cldx-20131231_def.xml EX-101.DEF 353541
Mailing Address 119 FOURTH AVE NEEDHAM MA 02494-2725
Business Address 119 FOURTH AVE NEEDHAM MA 02494 7814330771
Celldex Therapeutics, Inc. (Filer) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-15006 | Film No.: 14658945
SIC: 2835 In Vitro & In Vivo Diagnostic Substances